Profil
Dorrit T.
Andersen is currently working as a Regulatory Director at Galecto Biotech ApS.
Prior to this, she worked as a Director-Global Regulatory Affairs at Novo Nordisk A, Manager-Regulatory Affairs at Genmab A and Symphogen A, and Head-Regulatory Affairs at Ciba-Geigy Denmark.
Andersen completed her undergraduate degree at the University of Copenhagen.
Aktive Positionen von Dorrit T. Andersen
| Unternehmen | Position | Beginn |
|---|---|---|
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | General Counsel | - |
Ehemalige bekannte Positionen von Dorrit T. Andersen
| Unternehmen | Position | Ende |
|---|---|---|
Ciba-Geigy Denmark | General Counsel | - |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | General Counsel | - |
| GENMAB A/S | General Counsel | - |
| NOVO NORDISK A/S | General Counsel | - |
Ausbildung von Dorrit T. Andersen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Genmab A/S
Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Ciba-Geigy Denmark | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Health Technology |
















